64
Views
10
CrossRef citations to date
0
Altmetric
Review

Challenges posed to the maternal circulation by pregnancy

&
Pages 45-53 | Published online: 30 Aug 2011

References

  • Charnock-JonesDSKaufmannPMayhewTMAspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulationPlacenta20042510311314972443
  • KaufmannPBlackSHuppertzBEndovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsiaBiol Reprod2003691712620937
  • Red-HorseKZhouYGenbacevOTrophoblast differentiation during embryo implantation and formation of the maternal-fetal interfaceJ Clin Invest200411474475415372095
  • HyttenFBlood volume changes in normal pregnancyClin Haematol1985146016124075604
  • SalasSPRossoPEspinozaRRobertJAValdésGDonosoEMaternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardationObstet Gynecol199381102910338497346
  • GantNFDaleyGLChandSWhalleyPJMacDonaldPCA study of angiotensin II pressor response throughout primigravid pregnancyJ Clin Invest197352268226894355997
  • SalasSPMarshallGGutierrezBLRossoPTime course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restrictionHypertension20064720320816380519
  • KarlbergBERydénGWichmanKChanges in the renin-angiotensin-aldosterone and kallikrein-kinin systems during normal and hypertensive pregnancyActa Obstet Gynecol Scand19841181724
  • ValdésGKaufmannPCorthornJEricesRBrosnihanKBJoyner-GranthamJVasodilator factors in the systemic and local adaptations to pregnancyReprod Biol Endocrinol200977919646248
  • GryglewskiRJProstacyclin among prostanoidsPharmacol Rep20086031118276980
  • BussolinoFBenedettoCMassobrioMCamussiGMaternal vascular prostacyclin activity in pre-eclampsiaLancet198027026106815
  • YlikorkalaOPekonenFViinikkaLRenal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infantsJ Clin Endocrinol Metab198663130713123536979
  • CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant womenCLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative GroupLancet19943436196297906809
  • KnowlesRGMoncadaSNitric oxide synthases in mammalsBiochem J19942982492587510950
  • ConradKPJoffeGMKruszynaHIdentification of increased nitric oxide biosynthesis during pregnancy in ratsFASEB J199375665717682524
  • MolnarMSutoTTothTHertelendyFProlonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardationAm J Obstet Gynecol1994170145814667909994
  • YallampalliCGarfieldREInhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsiaAm J Obstet Gynecol1993169131613208238200
  • SavvidouMDHingoraniADTsikasDFrolichJCVallancePNicolaidesKHEndothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsiaLancet20033611511151712737861
  • MoreauMEGarbackiNMolinaroGBrownNJMarceauFAdamAThe kallikrein-kinin system: current and future pharmacological targetsJ Pharmacol Sci20059963816177542
  • ValdésGForadoriAOyarzúnEUrinary kallikrein along cycle, pregnancy and lactationPrenatal Neonatal Medicine19983474481
  • ElebuteOAMillsIHUrinary kallikrein in normal and hypertensive pregnanciesPerspect Nephrol Hypertens197653293381005045
  • KylePMCampbellSBuckleyDA comparison of the inactive urinary kallikrein:creatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsiaBr J Obstet Gynaecol19961039819878863695
  • FyhrquistFSaijonmaaORenin-angiotensin system revisitedJ Intern Med200826422423618793332
  • FerrarioCMBrosnihanKBDizDIAngiotensin-(1–7): a new hormone of the angiotensin systemHypertension1991185 SupplIII126III1331937675
  • TsutsumiYMatsubaraHMasakiHAngiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilationJ Clin Invest199910492593510510333
  • WiddopREMatrouguiKLevyBIHenrionDAT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockadeHypertension20024051652012364356
  • YayamaKHiyoshiHImazuDOkamotoHAngiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptorHypertension20064895896417000928
  • ColemanJKKrebsLTHamiltonTAAutoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in ratsPeptides1998192692779493859
  • MerrillDCKarolyMChenKFerrarioCMBrosnihanKBAngiotensin-(1–7) in normal and preeclamptic pregnancyEndocrine20021823924512450315
  • ValdésGGermainAMCorthornJUrinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactationEndocrine20011611712211887932
  • HerseFDechendRHarsemNKDysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsiaHypertension20074960461117261642
  • AbdAllaSLotherHel MassieryAQuittererUIncreased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsivenessNat Med200171003100911533702
  • ZhouACarrellRWMurphyMPA redox switch in angiotensinogen modulates angiotensin releaseNature201046810811120927107
  • DvorakHFBrownLFDetmarMDvorakAMVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisAm J Pathol1995146102910397538264
  • BrownbillPMillsTASoydemirDFSibleyCPVasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsiaPlacenta20082995095518845336
  • Wheeler-JonesCAbu-GhazalehRCospedalRHoulistonRAMartinJZacharyIVascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinaseFEBS Lett199742028329450544
  • TammelaTEnholmBAlitaloKPaavonenKThe biology of vascular endothelial growth factorsCardiovasc Res20056555056315664381
  • OlssonAKDimbergAKreugerJClaesson-WelshLVEGF receptor signalling – in control of vascular functionNat Rev Mol Cell Biol2006735937116633338
  • EvansPWWheelerTAnthonyFWOsmondCA longitudinal study of maternal serum vascular endothelial growth factor in early pregnancyHum Reprod199813105710629619570
  • BosioPMWheelerTAnthonyFConroyRO’HerlihyCMcKennaPMaternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistanceAm J Obstet Gynecol200118414615211174494
  • BrownbillPMcKeemanGCBrockelsbyJCCrockerIPSibleyCPVasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobuleEndocrinology20071484734474417640983
  • MaynardSEMinJYMerchanJExcess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJ Clin Invest200311164965812618519
  • LevineRJQianCMaynardSEYuKFEpsteinFHKarumanchiSASerum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous womenAm J Obstet Gynecol20061941034104116580293
  • WetzkaBNusingRCharnock-JonesDSSchaferWZahradnikHPSmithSKCyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnanciesHum Reprod199712231323209402302
  • WalshSWPreeclampsia: an imbalance in placental prostacyclin and thromboxane productionAm J Obstet Gynecol19851523353403923838
  • CravenCMMorganTWardKDecidual spiral artery remodelling begins before cellular interaction with cytotrophoblastsPlacenta1998192412529639319
  • NanaevAChwaliszKFrankHGKohnenGHegele-HartungCKaufmannPPhysiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblastCell Tissue Res19952824074218581935
  • FacchinettiFLongoMPiccininiFNeriIVolpeAL-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide releaseJ Soc Gynecol Investig19996202207
  • FacchinettiFSaadeGRNeriIPizziCLongoMVolpeAL-arginine supplementation in patients with gestational hypertension: a pilot studyHypertens Pregnancy20072612113017454224
  • GermainAMValdésGRomanikMCReyesMSEvidence supporting a beneficial role for long-term L-arginine supplementation in high-risk pregnanciesHypertension200444e115218885
  • NeriIJasonniVMGoriGFBlasiIFacchinettiFEffect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trialJ Matern Fetal Neonatal Med20061927728116753767
  • NorisMTodeschiniMCassisPL-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant speciesHypertension20044361462214744923
  • ValdésGChacónCCorthornJFigueroaCDGermainAMTissue kallikrein in human placenta in early and late gestationEndocrine20011419720411394637
  • ValdésGGermainAMCorthornJChacónCFigueroaCDMuller- EsterlWTissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestationEndocrine20011620721511954665
  • FuruyaMKurasawaKNagahamaKDisrupted balance of angiogenic and antiangiogenic signalings in preeclampsiaJ Pregnancy2011201112371721490787
  • EricesRCorthornJLisboaFValdésGBradykinin promotes migration and invasion of human immortalized trophoblastsReprod Biol Endocrinol201199721729302
  • Kreft-JaisCPlouinPFTchobroutskyCBoutroyMJAngiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalaprilBr J Obstet Gynaecol1988954204222838069
  • HanssensMKeirseMJVankelecomFVan AsscheFAFetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancyObstet Gynecol1991781281352047053
  • InoueIRohrwasserAHelinCA mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin systemJ Biol Chem199527011430114367744780
  • TakimotoEIshidaJSugiyamaFHoriguchiHMurakamiKFukamizuAHypertension induced in pregnant mice by placental renin and maternal angiotensinogenScience19962749959988875944
  • AntonLMerrillDCNevesLAActivation of local chorionic villi angiotensin II levels but not angiotensin (1–7) in preeclampsiaHypertension2008511066107218259034
  • AntonLMerrillDCNevesLAThe uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancyEndocrinology20091504316432519520788
  • WilliamsPJMistryHDInnesBABulmerJNPipkinFBExpression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the humanPlacenta3144845520304486
  • KrusselJSCasanEMRagaFExpression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometriumMol Hum Reprod1999545245810338368
  • MollerBLindblomBOlovssonMExpression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycleActa Obstet Gynecol Scand20028181782412225295
  • DemirRKayisliUASevalYSequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesisPlacenta20042556057215135240
  • CampbellSRoweJJacksonCJGalleryEDInteraction of cocultured decidual endothelial cells and cytotrophoblasts in preeclampsiaBiol Reprod20047124425215028631
  • ShiraishiSNakagawaKKinukawaNNakanoHSueishiKImmunohistochemical localization of vascular endothelial growth factor in the human placentaPlacenta1996171111218730881
  • DavidALTorondelBZacharyILocal delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheepGene Ther2008151344135018563186
  • ValdésGCorthornJReview: the angiogenic and vasodilatory uteroplacental networkPlacenta201132Suppl 2S170S17521295852
  • BellamyLCasasJPHingoraniADWilliamsDJPre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ200733597417975258
  • CraiciIMWagnerSJHaymanSRGarovicVDPre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular diseaseWomens Health20084133135
  • SmithGCPellJPWalshDPregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 birthsLancet20013572002200611438131
  • WilsonBJWatsonMSPrescottGJHypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort studyBMJ200332684512702615
  • IrgensHUReisaeterLIrgensLMLieRTLong term mortality of mothers and fathers after pre-eclampsia: population based cohort studyBMJ20013231213121711719411
  • VikseBEIrgensLMLeivestadTSkjaervenRIversenBMPreeclampsia and the risk of end-stage renal diseaseN Engl J Med200835980080918716297
  • ValdésGQuezadaFMarchantEAssociation of remote hypertension in pregnancy with coronary artery disease: a case-control studyHypertension20095373373819204177
  • YinonYKingdomJCOdutayoAVascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular riskCirculation20101221846185320956209
  • GermainAMRomanikMCGuerraIEndothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?Hypertension200749909517116761
  • BarkerDJThe developmental origins of adult diseaseJ Am Coll Nutr2004236 Suppl588S595S15640511
  • GluckmanPDHansonMACooperCThornburgKLEffect of in utero and early-life conditions on adult health and diseaseN Engl J Med2008359617318596274
  • RobsonSCHunterSBoysRJDunlopWSerial study of factors influencing changes in cardiac output during human pregnancyAm J Physiol1989256H1060H10652705548
  • PoppasAShroffSGKorcarzCESerial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial loadCirculation199795240724159170404
  • WilliamsDPregnancy: a stress test for lifeCurr Opin Obstet Gynecol20031546547114624211